ABEL SOTO: Open Payments
NPI 1740055045 · RAEFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $750 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $174 |
| GlaxoSmithKline, LLC. | 6 | $91 |
| Radius Health, Inc. | 4 | $89 |
| Corcept Therapeutics | 3 | $60 |
| PFIZER INC. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| ABBVIE INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 1 | $25 |
Products named: Ozempic, TRELEGY ELLIPTA, Tymlos, Korlym, JARDIANCE, NURTEC ODT, Kerendia, Rybelsus.
Industry payments across NC — which companies pay providers there.
